Trial Profile
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2024
Price :
$35
*
At a glance
- Drugs Catequentinib (Primary) ; Tislelizumab (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 13 Feb 2024 New trial record